Cyrus said the “top line data” will be publish
Post# of 145796
“ That would assume that the price stays at .36. An announcement of a trial with a release of previous results (preferably in a peer reviewed journal) should bump the price up. Preliminary results definitely would. So the entire burden wouldn't be at .36.”
Read More: https://investorshangout.com/post/newpost/605...z7jzmGu8zS
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)